Sort
51,593 grants matching “hepatitis”
Delaware Valley Node of the Clinical Trials Network
$1,250,000George E Woody · University Of Pennsylvania · U10 · FY2008 · DA
Florida Node of The Drug Abuse Clinical Trials Network
$1,250,000Jose Szapocznik · University Of Miami School Of Medicine · U10 · FY2008 · DA
Porphyria Rare Disease Clinical Research Consortium (RDCRC)
$1,250,000Robert J Desnick · Icahn School Of Medicine At Mount Sinai · U54 · FY2018 · DK
California-Arizona Clinical Trials Network Node
$1,250,000James L. Sorensen · University Of California, San Francisco · U10 · FY2006 · DA
Optimization of Antibiotics in Mothers and their Breastfed Infants Using Pharmacomicrobiomic and Metabolomic Analyses
$1,250,000Adriana H Tremoulet · University Of California, San Diego · P50 · FY2022 · HD
Florida Node of The Drug Abuse Clinical Trials Network
$1,250,000Jose Szapocznik · University Of Miami School Of Medicine · U10 · FY2007 · DA
Porphyria Rare Disease Clinical Research Consortium (RDCRC)
$1,250,000Robert J Desnick · Icahn School Of Medicine At Mount Sinai · U54 · FY2016 · DK
Porphyria Rare Disease Clinical Research Consortium (RDCRC)
$1,250,000Robert J Desnick · Icahn School Of Medicine At Mount Sinai · U54 · FY2014 · DK
Optimization of Antibiotics in Mothers and their Breastfed Infants Using Pharmacomicrobiomic and Metabolomic Analyses
$1,250,000Adriana H Tremoulet · University Of California, San Diego · P50 · FY2021 · HD
Clinical Trials Network: Long Island Regional Node
$1,250,000Edward V Nunes · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · U10 · FY2007 · DA
Delaware Valley Node of the Clinical Trials Network
$1,250,000George E Woody · University Of Pennsylvania · U10 · FY2007 · DA
Discovery of Pancreatic Signatures in Type 2 Diabetes Mellitus
$1,249,807Alvin Carter Powers · Vanderbilt University Medical Center · R24 · FY2019 · DK
Discovery of Pancreatic Signatures in Type 2 Diabetes Mellitus
$1,249,807Alvin Carter Powers · Vanderbilt University Medical Center · R24 · FY2017 · DK
Discovery of Pancreatic Signatures in Type 2 Diabetes Mellitus
$1,249,807Alvin Carter Powers · Vanderbilt University Medical Center · R24 · FY2018 · DK
Discovery of Pancreatic Signatures in Type 2 Diabetes Mellitus
$1,249,744Alvin Carter Powers · Vanderbilt University Medical Center · R24 · FY2016 · DK
DETERMINANTS OF INDIVIDUAL RESPONSIVENESS TO DRUGS
$1,249,472Vanderbilt University · P01 · FY2002 · GM
Molecular Mechanisms of TGF-beta Signaling Pathway
$1,248,960Ying Zhang · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment
$1,248,932Luis J. Montaner · Wistar Institute · R01 · FY2019 · DA
Porphyria Rare Disease Clinical Research Consortium (RDCRC)
$1,248,797Robert J Desnick · Icahn School Of Medicine At Mount Sinai · U54 · FY2015 · DK
Restoration of free radical homeostasis: novel therapy of septic shock
$1,248,631Andrew L Salzman · Radikal Therapeutics, Inc. · R44 · FY2016 · GM
Development of an Innovative Material for Transcatheter Peripheral Embolization
$1,247,814Ehsan Jabbarzadeh · Obsidio, Inc. · R44 · FY2022 · HL
Human pluripotent stem cells
$1,247,367Pamela Robey · National Institute Of Neurological Disorders And Stroke · ZIC · FY2015 · NS
CTN: Northern New England Node
$1,246,820Roger D. Weiss · Mclean Hospital · U10 · FY2007 · DA
Studies of HCV Infection And HCV-Host interactions
$1,246,721T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK
Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases
$1,246,547Patrizia Farci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI